Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: March 4, 2010
Event: Issuance of a press release during an investor meeting announcing forward-looking guidance.
Key Financial Metrics
This filing does not report historical financial results such as revenue, profit, cash flow, margins, debt, or liquidity for the current or prior periods. The document focuses exclusively on the announcement of future non-GAAP earnings guidance.
Material Changes
No material changes to historical financial performance are reported in this filing. The primary disclosure is the provision of minimum non-GAAP earnings per share guidance for the year 2013, subject to specific exclusions and assumptions.
Guidance, Outlook, and Risks
- Guidance: The company provided minimum non-GAAP earnings per share guidance for 2013.
- Limitations: The filing explicitly states there is no reasonably accessible or reliable comparable GAAP measure for this forward-looking information.
- Details: Specific numerical targets for the 2013 guidance are not included in the text of this 8-K; they are contained in the press release furnished as Exhibit 99.1.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the specific numerical values of the 2013 non-GAAP EPS guidance.
- Identify the specific exclusions and assumptions applied to the 2013 non-GAAP guidance.
- Verify the reconciliation between the non-GAAP guidance and the most recent GAAP results, noting the filing's statement that a reliable comparable GAAP measure may not exist for this forward-looking data.